Vaccines Jettisoned by CDC Safeguarded Millions From Disease

The federal government scaled back its recommended childhood vaccines, sidelining six that have safeguarded millions from serious diseases, long-term disability, and death.  Just three of those that the Centers for Disease Control and Prevention says it will no longer routinely recommend — against hepatitis A, hepatitis B, and rotavirus — have prevented nearly 2 million hospitalizations and 90,000 deaths in the…

Read More

Tienda de segunda mano. Clínica. Lugar de encuentro. Centro se convierte en espacio vital en medio de la crisis de vivienda y drogas

NUEVA ORLEANS, Louisiana. — Desde afuera, el antiguo local de la tienda Family Dollar, en el 9th Ward, luce intimidante. Está cubierto de grafitis y en el estacionamiento hay latas de aluminio y basura. Está ubicado en una calle con otros terrenos baldíos y edificios en ruinas: símbolos de la devastación persistente que este vecindario,…

Read More

State-Based Efforts Will Provide Limited Relief from Enhanced Tax Credit Expiration

After failed Senate votes late last year and no subsequent bipartisan agreement, the enhanced premium tax credits expired as of January 1. Some states, particularly those operating State-Based Marketplaces (SBMs), have been preparing for this possibility for months and are moving to blunt the impact on consumers by implementing their own state-funded subsidies and implementing…

Read More

Aktis Has First Biotech IPO of 2026, Raising $318M to Expand the Reach of Radiopharmaceuticals

Aktis Oncology’s IPO will support a pipeline of “miniprotein” radioconjugates that could offer advantages over other targeted radiation cancer treatments. In addition to its internal pipeline, Aktis has a discovery partnership with Eli Lilly. The post Aktis Has First Biotech IPO of 2026, Raising $318M to Expand the Reach of Radiopharmaceuticals appeared first on MedCity…

Read More